Katy Ovington

Senior Scientist | Biology | Oligonucleotide Therapeutics

Role
Senior Scientist at 4 59 Newco, A 5am Ventures Company
Location
Boston, MA, US
LinkedIn followers
500 followers
Research & DevelopmentView LinkedIn profile

About Katy Ovington

Entrepreneurial scientist with a track record of building venture-backed biotech…

Experience

  1. Senior Scientist

    4 59 Newco, A 5am Ventures Company

    Dec 2023 — Present

    Foundational scientist responsible for establishing and continually shaping critical and non-critical paths for both internal and CRO efforts to achieve go/no-go decision for small RNA-based upregulation therapeutics- Accountable for leading research through critical Proof of Concept activities to achieve company goals- Collaborative leader working closely with investors, board members, leadership, and founders to drive the company to PoC goals- Designed and performed experiments and industrialized assays that led to generation of high-quality data under tight timelines and communicated updates to leadership, investors and founders- Passionate and hands-on people manager who provided mentorship to junior scientist.

Education

  • Southern Illinois University School of Medicine

    Doctor of Philosophy - PhD, Biochemistry and Molecular Biology

  • Southern Illinois University, Carbondale

    Bachelor's degree, Kinesiology and Exercise Science

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Katy Ovington — Senior Scientist at 4 59 Newco, A 5am Ventures Company in Boston, MA, US | Unifers